Diagnostic approach to the congenital muscular dystrophies

[1]  K. Bushby,et al.  Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. , 2014, Human molecular genetics.

[2]  M. Devoto,et al.  Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice. , 2014, Human molecular genetics.

[3]  E. Bertini,et al.  Natural history of pulmonary function in collagen VI-related myopathies. , 2013, Brain : a journal of neurology.

[4]  K. Campbell,et al.  Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. , 2013, Molecular genetics and metabolism.

[5]  R. Weiss,et al.  Position of Glycine Substitutions in the Triple Helix of COL6A1, COL6A2, and COL6A3 is Correlated with Severity and Mode of Inheritance in Collagen VI Myopathies , 2013, Human mutation.

[6]  R. Carlier,et al.  Diaphragmatic dysfunction in Collagen VI myopathies , 2013, Neuromuscular Disorders.

[7]  D. MacArthur,et al.  Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. , 2013, American journal of human genetics.

[8]  L. Wilkins.  Severe congenital RYR1-associated myopathy: The expanding clinicopathologic and genetic spectrum , 2013, Neurology.

[9]  J. Carette,et al.  Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry , 2013, Science.

[10]  I. Nonaka,et al.  Rapidly progressive scoliosis and respiratory deterioration in Ullrich congenital muscular dystrophy , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  M. Hurles,et al.  Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. , 2013, American journal of human genetics.

[12]  L. Wells.  The O-Mannosylation Pathway: Glycosyltransferases and Proteins Implicated in Congenital Muscular Dystrophy* , 2013, The Journal of Biological Chemistry.

[13]  M. Hurles,et al.  ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies , 2013, Brain : a journal of neurology.

[14]  C. Fallet-Bianco,et al.  Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly. , 2012, American journal of human genetics.

[15]  C. Kuhl,et al.  Myopathy with lobulated fibers, cores, and rods caused by a mutation in collagen VI , 2012, Neurology.

[16]  Susana Quijano-Roy,et al.  Whole body muscle MRI protocol: Pattern recognition in early onset NM disorders , 2012, Neuromuscular Disorders.

[17]  S. Gabriel,et al.  Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. , 2012, American journal of human genetics.

[18]  E. Mercuri,et al.  The ever‐expanding spectrum of congenital muscular dystrophies , 2012, Annals of neurology.

[19]  K. Bushby,et al.  Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene‐associated myopathies , 2012, Human mutation.

[20]  M. Hegde,et al.  Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy. , 2012, The Journal of molecular diagnostics : JMD.

[21]  Christian Gilissen,et al.  Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan , 2012, Nature Genetics.

[22]  S. Shirakawa,et al.  Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy , 2012, Brain and Development.

[23]  Francesco Muntoni,et al.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome , 2012, Nature Genetics.

[24]  F. Muntoni,et al.  Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. , 2012, American journal of human genetics.

[25]  F. Muntoni,et al.  Flow cytometry analysis: A quantitative method for collagen VI deficiency screening , 2012, Neuromuscular Disorders.

[26]  R. Carlier,et al.  Muscle imaging in congenital myopathies. , 2011, Seminars in pediatric neurology.

[27]  J. Schuurs-Hoeijmakers,et al.  Autosomal Recessive Dilated Cardiomyopathy due to DOLK Mutations Results from Abnormal Dystroglycan O-Mannosylation , 2011, PLoS genetics.

[28]  I. Higuchi.  [Collagen VI-related muscle disorders]. , 2011, Brain and nerve = Shinkei kenkyu no shinpo.

[29]  Susan C. Brown,et al.  Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. , 2011, Current opinion in neurology.

[30]  I. Nonaka,et al.  Inflammatory changes in infantile-onset LMNA-associated myopathy , 2011, Neuromuscular Disorders.

[31]  E. Mercuri,et al.  173rd ENMC international workshop: Congenital muscular dystrophy outcome measures 5–7 March 2010, Naarden, The Netherlands , 2011, Neuromuscular Disorders.

[32]  R. Barresi.  From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies , 2011, Skeletal Muscle.

[33]  C. Bönnemann.  The collagen VI-related myopathies: muscle meets its matrix , 2011, Nature Reviews Neurology.

[34]  I. Nonaka,et al.  A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis. , 2011, American journal of human genetics.

[35]  F. Muntoni,et al.  Dystroglycanopathies: coming into focus. , 2011, Current opinion in genetics & development.

[36]  F. Muntoni,et al.  A dystroglycan mutation associated with limb-girdle muscular dystrophy. , 2011, The New England journal of medicine.

[37]  M. Main,et al.  P67 SEPN1 related myopathies: Clinical course in a large cohort of patients , 2011, Neuromuscular Disorders.

[38]  K. Campbell,et al.  Congenital muscular dystrophy type 1D (MDC1D) due to a large intragenic insertion/deletion, involving intron 10 of the LARGE gene , 2011, European Journal of Human Genetics.

[39]  Marni J. Falk,et al.  Large genomic deletions: A novel cause of Ullrich congenital muscular dystrophy , 2011, Annals of neurology.

[40]  B. Tseng,et al.  Consensus Statement on Standard of Care for Congenital Muscular Dystrophies , 2010, Journal of child neurology.

[41]  F. Rivier,et al.  Early onset collagen VI myopathies: Genetic and clinical correlations , 2010, Annals of neurology.

[42]  J. Groswasser,et al.  Novel LMNA mutation presenting as severe congenital muscular dystrophy. , 2010, Pediatric neurology.

[43]  B. Eymard,et al.  Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern , 2010, Neuromuscular Disorders.

[44]  K. Bushby,et al.  Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations , 2010, Neuromuscular Disorders.

[45]  E. Bertini,et al.  Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies , 2010, BMC Medical Genetics.

[46]  H. Worman,et al.  Diseases of the nuclear envelope. , 2010, Cold Spring Harbor perspectives in biology.

[47]  G. Vasco,et al.  Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine , 2010, Annals of neurology.

[48]  C. Bönnemann,et al.  Recessive COL6A2 C-globular Missense Mutations in Ullrich Congenital Muscular Dystrophy , 2010, The Journal of Biological Chemistry.

[49]  E. Mercuri,et al.  Autosomal recessive Bethlem myopathy , 2009, Neurology.

[50]  R. Weiss,et al.  Autosomal recessive inheritance of classic Bethlem myopathy , 2009, Neuromuscular Disorders.

[51]  E. Mercuri,et al.  CONGENITAL MUSCULAR DYSTROPHY WITH DEFECTIVE α-DYSTROGLYCAN, CEREBELLAR HYPOPLASIA, AND EPILEPSY , 2009, Neurology.

[52]  K. Bushby,et al.  Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. , 2009, Brain : a journal of neurology.

[53]  A. Krol,et al.  Selenoprotein function and muscle disease. , 2009, Biochimica et biophysica acta.

[54]  A. Aloysius,et al.  Natural history of Ullrich congenital muscular dystrophy , 2009, Neurology.

[55]  N. Romero,et al.  POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation. , 2009, European journal of medical genetics.

[56]  U. Reed.  Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives. , 2009, Arquivos de neuro-psiquiatria.

[57]  F. Muntoni,et al.  Oxidative stress in SEPN1‐related myopathy: From pathophysiology to treatment , 2009, Annals of neurology.

[58]  G. Comi,et al.  Congenital muscular dystrophies with defective glycosylation of dystroglycan , 2009, Neurology.

[59]  U. Reed.  Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects. , 2009, Arquivos de neuro-psiquiatria.

[60]  Mark W. Moyle,et al.  A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1‐related myopathy , 2009, Human mutation.

[61]  N. Romero,et al.  Four Caucasian patients with mutations in the fukutin gene and variable clinical phenotype , 2009, Neuromuscular Disorders.

[62]  E. Mercuri,et al.  Brain involvement in muscular dystrophies with defective dystroglycan glycosylation , 2008, Annals of neurology.

[63]  K. Mathews,et al.  Collagen VI glycine mutations: Perturbed assembly and a spectrum of clinical severity , 2008, Annals of neurology.

[64]  R. Sciot,et al.  Predominant fiber atrophy and fiber type disproportion in early ullrich disease , 2008, Muscle & nerve.

[65]  T. Crawford,et al.  Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle , 2008, Proceedings of the National Academy of Sciences.

[66]  E. Bertini,et al.  De novo LMNA mutations cause a new form of congenital muscular dystrophy , 2008, Annals of neurology.

[67]  U. Hansen,et al.  Three Novel Collagen VI Chains, α4(VI), α5(VI), and α6(VI)* , 2008, Journal of Biological Chemistry.

[68]  M. Pane,et al.  POMT1 and POMT2 mutations in CMD patients: A multicentric Italian study , 2008, Neuromuscular Disorders.

[69]  R. Finkel,et al.  Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance , 2008, Human mutation.

[70]  Machiel J Zwarts,et al.  Muscle ultrasound in neuromuscular disorders , 2008, Muscle & nerve.

[71]  C. Bönnemann,et al.  The phenotype and long-term follow-up in 11 patients with juvenile selenoprotein N1-related myopathy. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[72]  M. Paulsson,et al.  Three Novel Collagen VI Chains with High Homology to the α3 Chain* , 2008, Journal of Biological Chemistry.

[73]  K. Bushby,et al.  A refined diagnostic algorithm for Bethlem myopathy , 2008, Neurology.

[74]  F. Hentati,et al.  Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations. , 2008, Neuropediatrics.

[75]  N. Romero,et al.  Protein O-mannosyltransferase activities in lymphoblasts from patients with α-dystroglycanopathies , 2008, Neuromuscular Disorders.

[76]  A. Krol,et al.  Ex vivo correction of selenoprotein N deficiency in rigid spine muscular dystrophy caused by a mutation in the selenocysteine codon , 2007, Nucleic acids research.

[77]  N. Darín,et al.  Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I. , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[78]  Susan C. Brown,et al.  Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. , 2007, Brain : a journal of neurology.

[79]  E. Bertini,et al.  Phenotypic clustering of lamin A/C mutations in neuromuscular patients , 2007, Neurology.

[80]  B. V. van Engelen,et al.  Ehlers–Danlos syndrome due to tenascin‐X deficiency: Muscle weakness and contractures support overlap with collagen VI myopathies , 2007, American journal of medical genetics. Part A.

[81]  I. Nonaka,et al.  Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan , 2007, Neurology.

[82]  E. Brunner,et al.  Sensitivity and specificity of qualitative muscle ultrasound in assessment of suspected neuromuscular disease in childhood , 2007, Neuromuscular Disorders.

[83]  K. North,et al.  Variable penetrance of COL6A1 null mutations: Implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families , 2007, Neuromuscular Disorders.

[84]  H. Brunner,et al.  Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome , 2007, Human Genetics.

[85]  Susan C. Brown,et al.  Fukutin gene mutations in steroid‐responsive limb girdle muscular dystrophy , 2006, Annals of neurology.

[86]  K. Campbell,et al.  Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness , 2006, Annals of neurology.

[87]  S. Ellard,et al.  The laminopathies: a clinical review , 2006, Clinical genetics.

[88]  Susan C. Brown,et al.  A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations , 2006, Neuromuscular Disorders.

[89]  M. Pane,et al.  Expanding the clinical spectrum of POMT1 phenotype , 2006, Neurology.

[90]  R. Carlier,et al.  Brain MRI abnormalities in muscular dystrophy due to FKRP mutations , 2006, Brain and Development.

[91]  N. Petit,et al.  A single homozygous point mutation in a 3′untranslated region motif of selenoprotein N mRNA causes SEPN1‐related myopathy , 2006, EMBO reports.

[92]  N. Clarke,et al.  SEPN1: Associated with congenital fiber‐type disproportion and insulin resistance , 2006, Annals of neurology.

[93]  K. Campbell,et al.  Dystroglycan: from biosynthesis to pathogenesis of human disease , 2006, Journal of Cell Science.

[94]  Francesco Muntoni,et al.  Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders , 2005, Current opinion in neurology.

[95]  A. D’Amico,et al.  Two patients with ‘Dropped head syndrome’ due to mutations in LMNA or SEPN1 genes , 2005, Neuromuscular Disorders.

[96]  M. Huynen,et al.  POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome , 2005, Journal of Medical Genetics.

[97]  J. Allsop,et al.  Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Neuromuscular Disorders.

[98]  Susan C. Brown,et al.  Ullrich congenital muscular dystrophy: Connective tissue abnormalities in the skin support overlap with Ehlers–Danlos syndromes , 2005, American journal of medical genetics. Part A.

[99]  K. North,et al.  Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. , 2004, Human molecular genetics.

[100]  J. Bourke,et al.  Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant. , 2004, Archives of neurology.

[101]  F. Hanefeld,et al.  Desmin‐related myopathy with mallory body–like inclusions is caused by mutations of the selenoprotein N gene , 2004, Annals of neurology.

[102]  F. Muntoni,et al.  Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker–Warburg syndrome , 2004, Journal of Medical Genetics.

[103]  Y Suzuki,et al.  Ullrich disease due to deficiency of collagen VI in the sarcolemma , 2004, Neurology.

[104]  N. Romero,et al.  EMG and nerve conduction studies in children with congenital muscular dystrophy , 2004, Muscle & nerve.

[105]  F. Hanefeld,et al.  Muscle ultrasound in Bethlem myopathy. , 2003, Neuropediatrics.

[106]  Susan C. Brown,et al.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. , 2003, Human molecular genetics.

[107]  S. Marie,et al.  New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. , 2003, American journal of human genetics.

[108]  D. Gambi,et al.  Dysmyelinating sensory‐motor neuropathy in merosin‐deficient congenital muscular dystrophy , 2003, Muscle & nerve.

[109]  Susan C. Brown,et al.  Phenotypic spectrum associated with mutations in the fukutin‐related protein gene , 2003, Annals of neurology.

[110]  T. Toda,et al.  A new mutation of the fukutin gene in a non‐Japanese patient , 2003, Annals of neurology.

[111]  Susan C. Brown,et al.  Muscle MRI findings in a three-generation family affected by Bethlem myopathy. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[112]  C. Walsh,et al.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. , 2002, American journal of human genetics.

[113]  E. Mercuri,et al.  Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1) , 2002, Neuromuscular Disorders.

[114]  F. Muntoni,et al.  Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. , 2002, American journal of human genetics.

[115]  E. Bertini,et al.  Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[116]  Susan C. Brown,et al.  Congenital muscular dystrophies. , 2002, Seminars in pediatric neurology.

[117]  P. Guicheney,et al.  Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin) , 2002, European Journal of Human Genetics.

[118]  F. Baas,et al.  Kinked Collagen VI Tetramers and Reduced Microfibril Formation as a Result of Bethlem Myopathy and Introduced Triple Helical Glycine Mutations* , 2002, The Journal of Biological Chemistry.

[119]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. , 2001, American journal of human genetics.

[120]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. , 2001, Human molecular genetics.

[121]  M. Mizuno,et al.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. , 2001, Developmental cell.

[122]  K. North,et al.  Congenital muscular dystrophy with primary partial laminin α2 chain deficiency: Molecular study , 2001, Neurology.

[123]  F. Muntoni,et al.  Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome , 2001, Nature Genetics.

[124]  L. Morandi,et al.  Mild muscular dystrophy due to a nonsense mutation in the LAMA2 gene resulting in exon skipping. , 2001, Brain : a journal of neurology.

[125]  M. Leppert,et al.  Congenital muscular dystrophy with rigid spine syndrome: A clinical, pathological, radiological, and genetic study , 2000, Annals of neurology.

[126]  E. Berger,et al.  Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. , 2000, The Journal of clinical investigation.

[127]  N. Darín,et al.  Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden , 2000, Neuromuscular Disorders.

[128]  Y. Nakamura,et al.  Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). , 1999, Human molecular genetics.

[129]  G. Bydder,et al.  Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging , 1999, Neuromuscular Disorders.

[130]  M. Speer,et al.  Respiratory muscle involvement in Bethlem myopathy , 1999, Neurology.

[131]  I. Kanazawa,et al.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy , 1998, Nature.

[132]  Shun–ichi Kobayashi.  Tokyo campus rising , 1998, Nature.

[133]  I. Nonaka,et al.  A new congenital muscular dystrophy with mitochondrial structural abnormalities , 1998, Muscle & nerve.

[134]  C. Richelme,et al.  Genetics of laminin α2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis , 1997, Neuromuscular Disorders.

[135]  F. Muntoni,et al.  Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain , 1997, Neuromuscular Disorders.

[136]  C. Angelini,et al.  Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy , 1996, Human Genetics.

[137]  I. Nonaka,et al.  Congenital muscular dystrophy , 1996, Neurology.

[138]  N. Nevin,et al.  The prevalence of inherited neuromuscular disease in Northern Ireland , 1996, Neuromuscular Disorders.

[139]  F. Muntoni,et al.  Demyelinating Peripheral Neuropathy in Merosin-Deficient Congenital Muscular Dystrophy , 1995, Journal of child neurology.

[140]  F. Muntoni,et al.  Expression of laminin subunits in congenital muscular dystrophy , 1995, Neuromuscular Disorders.

[141]  K. Campbell,et al.  Congenital muscular dystrophy with merosin deficiency. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[142]  Marinos C. Dalakas,et al.  Muscle biopsy — a practical approach , 1986, The Ulster Medical Journal.

[143]  I. Nonaka,et al.  Congenital muscular dystrophy A histochemical study with morphometric analysis on biopsied muscles , 1985, Journal of the Neurological Sciences.

[144]  I. Nonaka,et al.  Muscle histochemistry in congenital muscular dystrophy with central nervous system involvement , 1982, Muscle & nerve.

[145]  I. Nonaka,et al.  A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy). , 1981, Neuropediatrics.

[146]  D. Escolar,et al.  Congenital muscular dystrophies. , 2011, Handbook of clinical neurology.

[147]  Irccs Bambino.  Expanding the clinical spectrum of POMT1 phenotype , 2006 .

[148]  T. Voit,et al.  Congenital muscular dystrophies: 1997 update , 1998, Brain and Development.

[149]  J. Weissenbach,et al.  Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. , 1995, Nature genetics.